203 related articles for article (PubMed ID: 34398362)
21. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
23. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Liu Z; Yang T; Xu Z; Cao X
Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
[TBL] [Abstract][Full Text] [Related]
25. Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.
Umeda S; Kanda M; Koike M; Tanaka H; Miwa T; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Kodera Y
Oncol Rep; 2018 Dec; 40(6):3772-3780. PubMed ID: 30272363
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of long noncoding RNA ANRIL correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Cao T; Shen J; Pan W; Li C; Qiao Z
J BUON; 2018; 23(6):1862-1866. PubMed ID: 30610814
[TBL] [Abstract][Full Text] [Related]
27. Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients.
Shinozuka T; Kanda M; Sato Y; Shimizu D; Tanaka C; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Cancer Med; 2023 Dec; 12(24):22185-22195. PubMed ID: 38014487
[TBL] [Abstract][Full Text] [Related]
28. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
29. Low expression of PINK1 and PARK2 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Lu X; Yao Y; Ma Y; Zhang X; Peng H; Pei Y; Lu Y; Wang L
World J Surg Oncol; 2023 Oct; 21(1):321. PubMed ID: 37833780
[TBL] [Abstract][Full Text] [Related]
30. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.
Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH
Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299
[TBL] [Abstract][Full Text] [Related]
33. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
[TBL] [Abstract][Full Text] [Related]
36. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
Li J; Li M; Gao F; Ge X
Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
[TBL] [Abstract][Full Text] [Related]
37. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.
Zhang BJ; Gong HY; Zheng F; Liu DJ; Liu HX
Int J Clin Exp Pathol; 2014; 7(9):6213-8. PubMed ID: 25337272
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
